Concepedia

Publication | Open Access

ImmunoPET Imaging with 89Zr-Labeled Atezolizumab Enables <i>In Vivo</i> Evaluation of PD-L1 in Tumorgraft Models of Renal Cell Carcinoma

DOIFull Paper Access

22

Citations

30

References

2022

Year

Aditi Mulgaonkar, Roy Elias, Layton Woolford, Bing Guan, Kien Nham, Payal Kapur, Alana Christie, Vanina Toffessi Tcheuyap, Nirmish Singla, I. Alex Bowman,
Clinical Cancer Research

Abstract

ImmunoPET with [89Zr]Zr-DFO-ATZ may enable a thorough and dynamic assessment of PD-L1 across sites of disease. The power of immunoPET to predict ICI response in RCC is being explored in an ongoing clinical trial (NCT04006522).

References

YearCitations

Page 1